TissueInformatics is a provider of a comprehensive tissue imaging, image analysis and image information management solution for the tissue engineering, pharmaceutical, genomics and related industry market sectors. The company specializes in the extraction of information from tissue using imaging technologies and related biological methods.

Paradigm Genetics, Inc. (NASD:PDGM) operates as a biotechnology company, which drives research and development productivity by focusing its suite of technologies on the product development cycle, from target discovery to the enhancement of safety and efficacy profiles.

Curtis was hired by TissueInformatics to conduct a comprehensive strategic alternatives review on behalf of TissueInformatics and its board of directors, culminating with the acquisition by Paradigm Genetics.